Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
949
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors

Gui-Ping WenState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public HealthXiamen University361102XiamenFujianPR China
,
Chang-Rong ChenState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public HealthXiamen University361102XiamenFujianPR China;Xiamen Blood Service361005XiamenFujianPR China;Xiamen Health Talent Service Center361003XiamenFujianChina
,
Xiu-Yu SongXiamen Blood Service361005XiamenFujianPR China
,
Zi-Min TangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public HealthXiamen University361102XiamenFujianPR China
,
Wen-Fang JiState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public HealthXiamen University361102XiamenFujianPR China;School of Life SciencesXiamen University361102XiamenFujianPR China
,
Si-Ling WangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public HealthXiamen University361102XiamenFujianPR China
,
Ke ZhangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public HealthXiamen University361102XiamenFujianPR China
,
Jun ZhangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public HealthXiamen University361102XiamenFujianPR China
,
Shan-Hai OuXiamen Blood Service361005XiamenFujianPR ChinaCorrespondence[email protected]
,
Zi-Zheng ZhengState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public HealthXiamen University361102XiamenFujianPR ChinaCorrespondence[email protected]
&
Ning-Shao XiaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public HealthXiamen University361102XiamenFujianPR China;School of Life SciencesXiamen University361102XiamenFujianPR ChinaORCID Iconhttp://orcid.org/0000-0003-0179-5266
ORCID Icon show all
Pages 1-8 | Received 12 Feb 2018, Accepted 27 May 2018, Published online: 05 Jul 2018

References

  • DaltonHRKamarNIzopetJHepatitis E in developed countries: current status and future perspectivesFuture Microbiol.20169 1361 137210.2217/fmb.14.89
  • Vollmer, T., Diekmann, J., Eberhardt, M., Knabbe, C. & Dreier, J. Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011. Euro Surveill. 21, 10.2807/1560-7917.ES.2016.21.35.30332 (2016).
  • SkidmoreSJYarboughPOGaborKAReyesGRHepatitis E virus: the cause of a waterbourne hepatitis outbreakJ. Med. Virol.199237586010.1002/jmv.1890370110
  • ArankalleVAChobeLPRetrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis EVox Sang.200079727410.1046/j.1423-0410.2000.7920072.x
  • Haim-BoukobzaSTransfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicityJ. Hepatol.2012571374137810.1016/j.jhep.2012.08.001
  • BoxallETransfusion-transmitted hepatitis E in a ‘nonhyperendemic’ countryTransfus. Med.200616798310.1111/j.1365-3148.2006.00652.x
  • MatsubayashiKA case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne routeTransfusion2008481368137510.1111/j.1537-2995.2008.01722.x
  • HogemaBMIncidence and duration of hepatitis E virus infection in Dutch blood donorsTransfusion20165672272810.1111/trf.13402
  • TedderRSVirology, serology, and demography of hepatitis E viremic blood donors in South East EnglandTransfusion2016561529153610.1111/trf.13498
  • RenFHepatitis E virus seroprevalence and molecular study among blood donors in ChinaTransfusion20145491091710.1111/trf.12530
  • Hewitt, P. E. et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet10.1016/s0140-6736(14)61034-5 (2014).
  • SatakeMUnique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppressionTransfusion20175728028810.1111/trf.13994
  • IdoloAIdentification of HEV in symptom-free migrants and environmental samples in ItalyJ. Viral Hepat.20132043844310.1111/jvh.12038
  • GuoQSPrevalence of hepatitis E virus in Chinese blood donorsJ. Clin. Microbiol.20104831731810.1128/JCM.01466-09
  • LiRCSeroprevalence of hepatitis E virus infection, rural southern People’s Republic of ChinaEmerg. Infect. Dis.2006121682168810.3201/eid1211.0603323372335
  • HuangSJProfile of acute infectious markers in sporadic hepatitis EPLoS ONE20105e1356010
  • BaylisSKocOumlNickSBlümelJWidespread distribution of hepatitis E virus in plasma fractionation poolsVox Sang.201210218218310.1111/j.1423-0410.2011.01527.x
  • Lucarelli, C. et al. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014. Euro Surveill. 21, 10.2807/1560-7917.ES.2016.21.30.30299 (2016).
  • KamarNHepatitis ELancet20123792477248810.1016/S0140-6736(11)61849-7
  • MyintKSAHepatitis E antibody kinetics in Nepalese patientsTrans. R. Soc. Trop. Med. Hyg.200610093894110.1016/j.trstmh.2005.12.005
  • GuptaEPandeyPPandeySSharmaMKSarinSKRole of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infectionJ. Clin. Virol.20135837437710.1016/j.jcv.2013.07.019
  • KamarNFactors associated with chronic hepatitis in patients with hepatitis e virus infection who have received solid organ transplantsGastroenterology20111401481148910.1053/j.gastro.2011.02.050
  • GengYDetection and assessment of infectivity of hepatitis E virus in urineJ. Hepatol.201664374310.1016/j.jhep.2015.08.034
  • Westholter, D. et al. HEV positive blood donations represent a relevant infection risk for immunosuppressed recipients. J. Hepatol. 10.1016/j.jhep.2018.02.031 (2018).
  • JothikumarNCromeansTLRobertsonBHMengXJHillVRA broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virusJ. Virol. Methods2006131657110.1016/j.jviromet.2005.07.004
  • WenGPA valuable antigen detection method for diagnosis of acute hepatitis EJ. Clin. Microbiol.20155378278810.1128/JCM.01853-144390668
  • ZhaoMA comprehensive study of neutralizing antigenic sites on the hepatitis e virus (hev) capsid by constructing, clustering, and characterizing a tool boxJ. Biol. Chem.2015290199101992210.1074/jbc.M115.6497644528150
  • ZhangFDetection of HEV antigen as a novel marker for the diagnosis of hepatitis EJ. Med. Virol.2006781441144810.1002/jmv.20717
  • BendallREllisVIjazSAliRDaltonHA comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countriesJ. Med. Virol.20108279980510.1002/jmv.21656
  • WenzelJJPreissJSchemmererMHuberBJilgWTest performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimatesJ. Infect. Dis.201320749750010.1093/infdis/jis688
  • ZhuFCEfficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trialLancet201037689590210.1016/S0140-6736(10)61030-6
  • ChapelHCunningham-RundlesCUpdate in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditionsBr. J. Haematol.200914570972710.1111/j.1365-2141.2009.07669.x2718064
  • AmeratungaRWoonSTGillisDKoopmansWSteeleRNew diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulinClin. Exp. Immunol.20131742032113828823
  • IjazSNon–travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristicsJ. Infect. Dis.20051921166117210.1086/444396
  • VollmerTNovel approach for detection of hepatitis E virus infection in German blood donorsJ. Clin. Microbiol.2012502708271310.1128/JCM.01119-123421526
  • JohneRDetection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCRJ. Gen. Virol.20109175075810.1099/vir.0.016584-0
  • MizuoHPolyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in JapanJ. Clin. Microbiol.2002403209321810.1128/JCM.40.9.3209-3218.2002130758

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.